Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

1.3K
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Severe clinical phenotypes of heterozygous females with X-linked chronic granulomatous disease.

The journal of allergy and clinical immunology. In practice·2024
Same author

COVID-19 Vaccination in Patients with Inborn Errors of Immunity Reduces Hospitalization and Critical Care Needs Related to COVID-19: a USIDNET Report.

Journal of clinical immunology·2024
Same author

Safety and Efficacy of Hizentra® Following Pediatric Hematopoietic Cell Transplant for Treatment of Primary Immunodeficiencies.

Journal of clinical immunology·2023
Same author

Natural history of infants with non-SCID T cell lymphopenia identified on newborn screen.

Clinical immunology (Orlando, Fla.)·2022
Same author

Corrigendum: Case report: Initial treatment adjustments and complications in ovarian cancer patient with inborn error of immunity.

Frontiers in oncology·2022
Same author

Case Report: Initial Treatment Adjustments and Complications in Ovarian Cancer Patient With Inborn Error of Immunity.

Frontiers in oncology·2022

Related Experiment Video

Updated: Apr 19, 2026

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

24.3K

Subcutaneous immunoglobulin replacement therapy: ensuring success.

M Elizabeth M Younger1, William Blouin, Carla Duff

  • 1Johns Hopkins University School of Medicine, Baltimore, Maryland (Dr Younger); Miami Children's Hospital, Miami, Florida (Mr Blouin); University of South Florida/All Children's Hospital, St. Petersburg, Florida (Ms Duff); Midwest Immunology Clinic, Plymouth, Minnesota (Ms Epland); and CSL Behring, King of Prussia, Pennsylvania (Ms Murphy); and Duke University Medical Center, Durham, North Carolina (Ms Sedlak). M. Elizabeth M. Younger, PhD, CRNP, is an assistant professor of pediatrics and a pediatric nurse practitioner in the Division of Pediatric Immunology at Johns Hopkins University School of Medicine in Baltimore, Maryland. She has extensive experience with managing immunoglobulin therapy for antibody-deficient patients. William Blouin, MSN, ARNP, CPNP, works in pediatric allergy and immunology at Miami Children's Hospital, Miami, Florida. With more than 35 years of experience in pediatrics, his interests and expertise are allergy, human immunodeficiency virus, immunology, infusion, and transplantation. Carla Duff, MSN, CPNP, CCRP, is a nurse practitioner in pediatric allergy and immunology at the University of South Florida/All Children's Hospital, St. Petersburg, Florida. She has many years of experience with clinical immunology and managing immunoglobulin replacement therapy for primary immunodeficiency patients. Kristin Buehler Epland, MSN, FNP, is a family nurse practitioner specializing in the care and diagnosis of primary immunodeficiencies and autoimmune diseases at Midwest Immunology Clinic, Plymouth, Minnesota. She has worked with immunodeficient patients through home and clinic infusion nursing. Elyse Murphy, BSN, RN, is a medical science liaison with CSL Behring in King of Prussia, Pennsylvania, and has more than 30 years of expertise in immunoglobulin therapies in immunology, hematology-oncology, neurology, and transplant therapeutic areas. Debra Sedlak, CPNP, has more than 30 years of experience in clinical immunology in the Division of Pediatric A

Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society
|December 30, 2014
PubMed
Summary

Subcutaneous immunoglobulin (SCIg) infusions offer a treatment option for patients needing immunoglobulin therapy. Nurses can empower patients with essential teaching for successful self-management of SCIg infusions.

More Related Videos

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
10:35

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

8.8K
Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

11.0K

Related Experiment Videos

Last Updated: Apr 19, 2026

Intralymphatic Immunotherapy and Vaccination in Mice
07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

24.3K
Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
10:35

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

8.8K
Granulocyte-dependent Autoantibody-induced Skin Blistering
12:23

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

11.0K

Area of Science:

  • Immunology
  • Patient Education

Background:

  • Immunoglobulin therapy is crucial for various conditions.
  • Subcutaneous immunoglobulin (SCIg) infusions present an alternative administration route.
  • Nurses play a vital role in patient care and education for complex therapies.

Purpose of the Study:

  • To review the fundamentals of subcutaneous immunoglobulin (SCIg) therapy.
  • To provide comprehensive teaching strategies for patients undergoing SCIg infusions.
  • To offer practical tips for ensuring successful patient self-management of SCIg therapy.

Main Methods:

  • Literature review on SCIg therapy.
  • Synthesis of current clinical guidelines and best practices.
  • Development of patient education modules and resources.

Main Results:

  • SCIg infusions are a viable option for immunoglobulin replacement therapy.
  • Effective patient education is key to successful self-administration.
  • Creative strategies can enhance patient adherence and treatment outcomes.

Conclusions:

  • Nurses are essential in educating and supporting patients for SCIg therapy.
  • Empowering patients with knowledge promotes independence and treatment success.
  • Optimizing SCIg administration through education improves patient quality of life.